Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Exploring Diverse Mechanisms of Type III CRISPR-Cas signaling.

Award Number: R35GM156941
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/03/2025
PERIOD OF PERFORMANCE END DATE: 02/28/2030

Group Awards By:

View Award Description

Exploring Diverse Mechanisms of Type III CRISPR-Cas signaling. - PROJECT SUMMARY Exploring Diverse Mechanisms of Type III CRISPR-Cas signaling Microbes called bacteria and archaea are the most abundant organisms on Earth and play an essential role in our health and well-being. Like us, they use sophisticated mechanisms to defend themselves from viral infection. Our proposed research focuses on molecular mechanisms of adaptive immunity in prokaryotes, which is mediated by CRISPR-Cas systems. These pathways use RNA-guided interference complexes to target complementary sequences in foreign DNA or RNA for degradation, leading to immunity against phages and other mobile genetic elements. Recent studies on widespread Type III CRISPR-Cas systems show that their RNA-guided interference complexes not only degrade nucleic acids, but also produce cyclic oligoadenylates that act as second messenger molecules to activate a network of signaling effectors, including nucleases, proteases, and membrane proteins. While a diverse array of Type III CRISPR signaling effectors have been identified bioinformatically, our understanding of their function and mechanism remains limited. Our lab aims to understand the mechanisms underlying the function and regulation of these signaling effectors, focusing on two major groups: 1) nucleases, which are the largest group of signaling effectors associated with Type III CRISPR systems, and 2) membrane proteins, since they represent a fascinating new frontier of CRISPR-Cas tools and microbial defense biology. We plan to use biochemistry and structural biology to investigate how signaling effector nucleases are regulated by cyclic nucleotide second messenger molecules. Membrane proteins that are associated with Type III CRISPR-Cas systems also suggest intriguing new connections between RNA-guided antiviral immunity and cellular membrane processes in microbes. We hypothesize that CRISPR-associated membrane proteins perturb membrane integrity to cause cell death, and aim to use a combination of biochemistry, cell biology, and structural biology tools to define the function, mechanism, and regulation of these proteins. Taken together, this has the potential to reveal insights that could redefine paradigms for antiviral defense, as well as spur the development of novel point-of-care diagnostics, RNA sensors, and tools for controlling cell behavior.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $392,500 )
2026	2026	RUTGERS THE STATE UNIVERSITY OF NEW JERSEY	65 BERGEN ST	NEWARK	NJ	07107	ESSEX	USA	Biomedical Research and Research Training	000	2	3/2/2026	NON-COMPETING CONTINUATION	$392,500
														Subtotal = $392,500

Issue Date FY: 2025 ( Subtotal = $360,247 )
2025	2025	RUTGERS THE STATE UNIVERSITY OF NEW JERSEY	65 BERGEN ST	NEWARK	NJ	07107	ESSEX	USA	Biomedical Research and Research Training	000	1	4/3/2025	NEW	$360,247
														Subtotal = $360,247

Grand Total All Awards = $752,747

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Exploring Diverse Mechanisms of Type III CRISPR-Cas signaling.

Award Number: R35GM156941

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/03/2025

PERIOD OF PERFORMANCE END DATE: 02/28/2030

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer